Acquired severe aplastic anemia (SAA) is a rare hematologic disease associated with
significant morbidity and mortality. Immune destruction of hemopoietic stem cells plays an …

This review examines the evidence that bone marrow failure (BMF) in aplastic anaemia (AA)
is due to loss of haematopoietic stem cells (HSC s), which, in turn, is caused by deranged …

Severe aplastic anemia (SAA) is a life-threatening disease that can be cured with allogeneic
cell transplantation (HCT). Haploidentical donor transplantation with post-transplantation …

Newly diagnosed aplastic anemia is a serious condition, with more than 75%(higher in
young patients) becoming long-term survivors if diagnosed and treated appropriately. First …

Acquired aplastic anemia is a potentially fatal bone marrow failure disorder that is
characterized by pancytopenia and a hypocellular bone marrow. Hematopoietic stem-cell …

Aplastic anemia (AA), a potentially fatal disease, may be cured with marrow transplantation.
Survival in pediatric patients has been excellent early after transplantation, but only limited …

Трансплантация гемопоэтических стволовых клеток (ТГСК) является ведущим методом
лечения злокачественных заболеваний системы крови и наследственных …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely applied for the
treatment of hematologic malignancies, but autologous hematopoietic recovery (AR) after …

Background Graft failure (GF) is a rare but serious complication after allogeneic
hematopoietic stem cell transplantation (HSCT). Prevention of graft failure remains the most …

There have been sporadic reports of the development of delayed disease recurrence after
bone marrow transplantation for severe aplastic anemia despite sustained majority or full …